SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Max Medical Services Ltd. - (Amalgamated)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: Construction - Real Estate | Small Cap | Max Medical Services Share Price

BSE Share Price
Not Listed

Max Medical Services Ltd. - (Amalgamated)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: Construction - Real Estate | Small Cap | Max Medical Services Share Price

BSE Share Price
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹0 Cr.
Current Price
₹0
52-Week Low / High
₹0 / 0
TTM EPS
₹0
TTM Sales
₹44.2 Cr.
Book Value per Share
-
P/E Ratio
0.00
Industry PE
47.9
Price to Book (P/B)
0.00
Price to Sales (P/S)
0.00
EV/EBITDA
0.00
Dividend Yield
NAN%
Profitability Efficiency
Return on Equity (ROE)
16.28%
Return on Capital Employed (ROCE)
14.54%
Return on Assets (ROA)
9.71%
Operating Profit Margin
42.8%
Net Profit Margin
31.92%
Gross Profit Margin
51.7%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
2.91%
Operating Profit Growth (1 Year)
Slowing versus 3-year growth rate
12.54%
Net Profit Growth (1 Year)
-
145.39%
Asset Quality
Promoter Holding
%
Pledged shares (%) of Promoter's holding (%)
%
Reserves
₹60 Cr.
Equity
₹0 Cr.
Face Value
₹10
All Time Low / High
- / -

Max Medical Services . - (Amalgamated) stock performance

Key Ratios
mw4me loader

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16TTM
ROCE % 9.5%5%6.5%7.3%6.9%8.7%10.1%14.5%-

Growth Parameters

Sales 26.656.844.848.75542.44344.244
Sales YoY Gr.-113.3%-21.1%8.6%13.1%-22.9%1.3%2.9%-
Adj EPS 1.8-6.1-9.4-3.2-0.301.74.10
YoY Gr.--438.6%NANANANANA145.8%-
BVPS (₹) 5-0.2-9.522.121.821.823.327.50
Adj Net
Profit
2.5-8.6-13.3-10.9-105.814.10
Cash Flow from Ops. 3.13.72.649.646.765.37.536.8-
Debt/CF from Ops. 45.45384.42.42.418.50.9-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales NA-0.3%-7%2.9%
Adj EPS NANANA145.8%
BVPSNANA8%17.8%
Share Price - - - -

Key Financial Parameters

Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16TTM
Return on
Equity %
31.9-223.7193.6-35.2-1.407.516.30
Op. Profit
Mgn %
39.49.123.725.919.13139.242.8NAN
Net Profit
Mgn %
9.5-15.1-29.6-22.5-1.9013.431.90
Debt to
Equity
19.9-740.5-16.31.61.50.90.80.4-
Working Cap
Days
09901,4041,2499178175935730
Cash Conv.
Cycle
031032042753531042890

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16
Sales26.6256.7944.8248.6655.0342.4142.9644.21
Operating Expenses + 16.1751.9834.2036.0444.5129.2826.1325.27
Manufacturing Costs3.193.392.733.963.550.0100
Material Costs11.0446.6129.1528.3638.6127.2624.7724.15
Employee Cost 0.270.390.020.031.291.441.080.59
Other Costs 1.661.592.303.691.060.570.280.53
Operating Profit 10.454.8110.6212.6210.5213.1316.8318.94
Operating Profit Margin (%) 39.3%8.5%23.7%25.9%19.1%31.0%39.2%42.8%
Other Income + 6.417.908.609.099.708.308.489.49
Exceptional Items 00000000
Interest 16.6917.4726.1525.8414.1913.778.645.56
Depreciation 2.904.036.236.987.047.3010.928.76
Profit Before Tax -2.73-8.79-13.16-11.11-1.010.365.7514.11
Tax -5.23-0.590-0.1900.3600
Profit After Tax 2.50-8.20-13.16-10.92-1.0105.7514.11
PAT Margin (%) 9.4%-14.4%-29.4%-22.4%-1.8%0.0%13.4%31.9%
Adjusted EPS (₹)1.8-5.8-9.3-3.2-0.30.01.74.1
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%

Valuation of Max Medical Services - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16

Equity and Liabilities

Shareholders Fund + 7.94-0.27-13.4375.5574.5474.5479.6393.74
Share Capital 14.1414.1414.1434.1434.1434.1434.1434.14
Reserves -6.21-14.41-27.5741.4140.4040.4045.4959.60
Debt +140.26197.34217.80118.98108.8766.8363.6333.48
Long Term Debt140.26197.343.211.73066.8363.6333.48
Short Term Debt00214.59117.25108.87000
Minority Interest00000000
Trade Payables5.2710.817.60911.6011.279.797.76
Others Liabilities 38.8541.5761.6738.4425.140.202.280.22
Total Liabilities 192.32249.45273.64241.97220.15152.84155.33135.20

Fixed Assets

Net Fixed Assets +31.3570.6872.1776.2869.8062.2650.8144.75
Gross Block43.8187.0394.74105.83106.37104.13102.60103.24
Accumulated Depreciation12.4616.3522.5729.5536.5741.8751.7958.49
CWIP 1.390.375.820002.640.47
Investments 13.4813.4813.4813.4825.4825.4825.4825.48
Inventories01.900.0700000.05
Trade Receivables54.7956.5941.4892.6891.147.6926.8317.84
Cash Equivalents 0.511.640.680.600.110.061.780.22
Others Assets 90.80104.80139.9458.9333.6257.3547.7946.39
Total Assets 192.32249.45273.64241.97220.15152.84155.33135.20

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16
Cash Flow From Operating Activity + 3.093.722.6049.6446.6665.287.5236.75
PBT -2.73-8.79-13.16-11.11-1.010.365.7514.11
Adjustment 20.4424.042.593.384.4819.6310.668.55
Changes in Working Capital -14.61-11.52-13.631.3229.0445.77-17.589.76
Tax Paid 000.6200-0.500.05-1.23
Cash Flow From Investing Activity + -2.37-41.93-13.20-4.13-10.279.823.81-0.38
Capex 0-43.74-13.22-5.27-0.570.22-1.36-2.14
Net Investments -0.010000000
Others -2.361.810.021.14-9.709.605.171.76
Cash Flow From Financing Activity -0.5339.349.64-45.59-36.88-75.15-11.32-36.22
Net Proceeds from Shares + 0001000000
Net Proceeds from Borrowing 11.6457.08000000
Interest Paid -12.17-17.74-7.60-49.19-27.46-33.11-8.12-6.07
Dividend Paid 00000000
Others 0017.24-96.40-9.42-42.04-3.20-30.15
Net Cash Flow 0.191.14-0.96-0.08-0.49-0.050.010.15

Financial Ratio

PARTICULARSMar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16
Ratios
ROE (%)35.37N/AN/A-35.16-1.3507.4616.28
ROCE (%)9.47N/AN/A7.326.918.6510.1114.54
Asset Turnover Ratio0.140.260.170.190.240.230.280.3
PAT to CFO Conversion(x)1.24N/AN/AN/AN/AN/A1.312.6
Working Capital Days
Receivable Days751.40357.90399.30503.20609.60425.30146.70184.40
Inventory Days06.10800000.40
Payable Days174.3063115.20106.8097.40153.10155.20132.60

Management X-Ray

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Max Medical Services Ltd. - (Amalgamated) FAQs

The current trading price of Max Medical Services on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Max Medical Services stood at ₹0.00 Cr

The latest P/E ratio of Max Medical Services as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Max Medical Services as of 31-Dec-1969 is 0.00.

The 52-week high of Max Medical Services is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Max Medical Services is ₹44.21 ( Cr.) .

Data is not available for this company.

No data found

No data found

About Max Medical Services Ltd. - (Amalgamated)

No data to display
You have 1 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: